Allergen (AGN) Impact from EU Breast Implants 'Relatively Small' - Wells Fargo's Maris
Tweet Send to a Friend
Wells Fargo analyst David Maris weighed in on Allergen (NYSE: AGN) after the suspended sales of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
